{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:51:11Z","timestamp":1794271871462,"version":"4.9.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-58910-3","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:06:57Z","timestamp":1744762017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Integrative proteogenomic characterization reveals therapeutic targets in poorly differentiated and anaplastic thyroid cancers"],"prefix":"10.1038","volume":"16","author":[{"given":"Zongfu","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenmei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbiao","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liehao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingyi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulu","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4437-0268","authenticated-orcid":false,"given":"Zhaoyu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4355-8162","authenticated-orcid":false,"given":"Xiaozhou","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiefeng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3869-7651","authenticated-orcid":false,"given":"Tiannan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7613-648X","authenticated-orcid":false,"given":"Yaoting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changtian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8673-3464","authenticated-orcid":false,"given":"Chen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1775-029X","authenticated-orcid":false,"given":"Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6726-6418","authenticated-orcid":false,"given":"Minghua","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"58910_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA A Cancer J. Clin."},{"key":"58910_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1089\/thy.2020.0944","volume":"31","author":"KC Bible","year":"2021","unstructured":"Bible, K. C. et al. 2021 American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid 31, 337\u2013386 (2021).","journal-title":"Thyroid"},{"key":"58910_CR3","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI85271","volume":"126","author":"I Landa","year":"2016","unstructured":"Landa, I. et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J. Clin. Investig. 126, 1052\u20131066 (2016).","journal-title":"J. Clin. Investig."},{"key":"58910_CR4","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1158\/1078-0432.CCR-18-0373","volume":"24","author":"N Pozdeyev","year":"2018","unstructured":"Pozdeyev, N. et al. Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers. Clin. Cancer Res. 24, 3059\u20133068 (2018).","journal-title":"Clin. Cancer Res."},{"key":"58910_CR5","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1056\/NEJMra1501993","volume":"375","author":"JA Fagin","year":"2016","unstructured":"Fagin, J. A. & Wells, S. A. Biologic and clinical perspectives on thyroid cancer. N. Engl. J. Med. 375, 1054\u20131067 (2016).","journal-title":"N. Engl. J. Med."},{"key":"58910_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1200\/JCO.2017.73.6785","volume":"36","author":"V Subbiah","year":"2018","unstructured":"Subbiah, V. et al. Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600\u2013mutant anaplastic thyroid cancer. J. Clin. Oncol.\u00a036, 7\u201313 (2018).","journal-title":"J. Clin. Oncol"},{"key":"58910_CR7","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1093\/hmg\/ddu749","volume":"24","author":"JW Kunstman","year":"2015","unstructured":"Kunstman, J. W. et al. Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing. Hum. Mol. Genet. 24, 2318\u20132329 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"58910_CR8","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1200\/JCO.19.02727","volume":"38","author":"J Capdevila","year":"2020","unstructured":"Capdevila, J. et al. PD-1 blockade in anaplastic thyroid carcinoma. J. Clin. Oncol. 38, 2620\u20132627 (2020).","journal-title":"J. Clin. Oncol."},{"key":"58910_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113826","volume":"43","author":"PYF Zeng","year":"2024","unstructured":"Zeng, P. Y. F. et al. The genomic and evolutionary landscapes of anaplastic thyroid carcinoma. Cell Rep. 43, 113826 (2024).","journal-title":"Cell Rep."},{"key":"58910_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10680-5","volume":"10","author":"S-K Yoo","year":"2019","unstructured":"Yoo, S.-K. et al. Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer. Nat. Commun. 10, 2764 (2019).","journal-title":"Nat. Commun."},{"key":"58910_CR11","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1158\/1078-0432.CCR-17-3089","volume":"24","author":"KAP Schultz","year":"2018","unstructured":"Schultz, K. A. P. et al. DICER1 and associated conditions: identification of at-risk individuals and recommended surveillance strategies. Clin. Cancer Res. 24, 2251\u20132261 (2018).","journal-title":"Clin. Cancer Res."},{"key":"58910_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-024-02726-w","volume":"147","author":"E Karimi","year":"2024","unstructured":"Karimi, E. et al. Characterization of NEB pathogenic variants in patients reveals novel nemaline myopathy disease mechanisms and omecamtiv mecarbil force effects. Acta. Neuropathol.\u00a0147, 72 (2024).","journal-title":"Acta. Neuropathol"},{"key":"58910_CR13","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1101\/gad.14.8.927","volume":"14","author":"Y Wang","year":"2000","unstructured":"Wang, Y. et al. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14, 927\u2013939 (2000).","journal-title":"Genes Dev."},{"key":"58910_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.apsb.2019.09.004","volume":"10","author":"F Li","year":"2020","unstructured":"Li, F. et al. PCC0208017, a novel small-molecule inhibitor of MARK3\/MARK4, suppresses glioma progression in vitro and in vivo. Acta Pharm. Sin. B 10, 289\u2013300 (2020).","journal-title":"Acta Pharm. Sin. B"},{"key":"58910_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2023386","volume":"384","author":"DRW Jayne","year":"2021","unstructured":"Jayne, D. R. W., Merkel, P. A., Schall, T. J. & Bekker, P. Avacopan for the treatment of ANCA-associated vasculitis. N. Engl. J. Med. 384, 599\u2013609 (2021).","journal-title":"N. Engl. J. Med."},{"key":"58910_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47581-1","volume":"15","author":"N Qu","year":"2024","unstructured":"Qu, N. et al. Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks. Nat. Commun. 15, 3175 (2024).","journal-title":"Nat. Commun."},{"key":"58910_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2024.105260","volume":"306","author":"L Peng","year":"2024","unstructured":"Peng, L., Zhang, Z., Du, W., Zhu, J. & Duan, W. Proteomic and Phosphoproteomic analysis of thyroid papillary carcinoma: Identification of potential biomarkers for metastasis. J. Proteom. 306, 105260 (2024).","journal-title":"J. Proteom."},{"key":"58910_CR18","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1021\/acs.jproteome.5b01136","volume":"15","author":"S Shao","year":"2016","unstructured":"Shao, S. et al. Reproducible tissue homogenization and protein extraction for quantitative proteomics using MicroPestle-assisted pressure-cycling technology. J. Proteome Res. 15, 1821\u20131829 (2016).","journal-title":"J. Proteome Res."},{"key":"58910_CR19","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1002\/1878-0261.12570","volume":"13","author":"Y Zhu","year":"2019","unstructured":"Zhu, Y. et al. High\u2010throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification. Mol. Oncol. 13, 2305\u20132328 (2019).","journal-title":"Mol. Oncol."},{"key":"58910_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17385-0","volume":"11","author":"J-J Yu","year":"2020","unstructured":"Yu, J.-J. et al. TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target. Nat. Commun. 11, 3660 (2020).","journal-title":"Nat. Commun."},{"key":"58910_CR21","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s41388-019-1046-5","volume":"39","author":"CB Williams","year":"2020","unstructured":"Williams, C. B. et al. HUNK phosphorylates EGFR to regulate breast cancer metastasis. Oncogene 39, 1112\u20131124 (2020).","journal-title":"Oncogene"},{"key":"58910_CR22","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41388-020-01564-w","volume":"40","author":"G Kaushik","year":"2021","unstructured":"Kaushik, G. et al. Selective inhibition of stemness through EGFR\/FOXA2\/SOX9 axis reduces pancreatic cancer metastasis. Oncogene 40, 848\u2013862 (2021).","journal-title":"Oncogene"},{"key":"58910_CR23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI169653","volume":"133","author":"L Lu","year":"2023","unstructured":"Lu, L. et al. Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. J. Clin. Investig. 133, e169653 (2023).","journal-title":"J. Clin. Investig."},{"key":"58910_CR24","doi-asserted-by":"crossref","unstructured":"McFadden, D. G. et al. p53 constrains progression to anaplastic thyroid carcinoma in a Braf -mutant mouse model of papillary thyroid cancer. Proc. Natl. Acad. Sci. USA 111, E1600\u20131609 (2014).","DOI":"10.1073\/pnas.1404357111"},{"key":"58910_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.trecan.2020.08.003","volume":"7","author":"S Bursa\u0107","year":"2021","unstructured":"Bursa\u0107, S., Prodan, Y., Pullen, N., Bartek, J. & Volarevi\u0107, S. Dysregulated ribosome biogenesis reveals therapeutic liabilities in cancer. Trends Cancer\u00a07, 57\u201376 (2021).","journal-title":"Trends Cancer"},{"key":"58910_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00974-5","volume":"20","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. RRP9 promotes gemcitabine resistance in pancreatic cancer via activating AKT signaling pathway. Cell Commun. Signal. 20, 188 (2022).","journal-title":"Cell Commun. Signal."},{"key":"58910_CR27","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1158\/0008-5472.CAN-21-4087","volume":"82","author":"AR Elhamamsy","year":"2022","unstructured":"Elhamamsy, A. R., Metge, B. J., Alsheikh, H. A., Shevde, L. A. & Samant, R. S. Ribosome biogenesis: a central player in cancer metastasis and therapeutic resistance. Cancer Res. 82, 2344\u20132353 (2022).","journal-title":"Cancer Res."},{"key":"58910_CR28","doi-asserted-by":"publisher","first-page":"9613","DOI":"10.1073\/pnas.0901997106","volume":"106","author":"S Granneman","year":"2009","unstructured":"Granneman, S., Kudla, G., Petfalski, E. & Tollervey, D. Identification of protein binding sites on U3 snoRNA and pre-rRNA by UV cross-linking and high-throughput analysis of cDNAs. Proc. Natl. Acad. Sci. USA 106, 9613\u20139618 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"58910_CR29","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1093\/nar\/gkaa066","volume":"48","author":"G Clerget","year":"2020","unstructured":"Clerget, G. et al. Synergistic defects in pre-rRNA processing from mutations in the U3-specific protein Rrp9 and U3 snoRNA. Nucleic Acids Res. 48, 3848\u20133868 (2020).","journal-title":"Nucleic Acids Res."},{"key":"58910_CR30","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"M Pollak","year":"2008","unstructured":"Pollak, M. Insulin and insulin-like growth factor signalling in neoplasia. Nat. Rev. Cancer 8, 915\u2013928 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"58910_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111759","volume":"41","author":"J-S Lee","year":"2022","unstructured":"Lee, J.-S. et al. The insulin and IGF signaling pathway sustains breast cancer stem cells by IRS2\/PI3K-mediated regulation of MYC. Cell Rep. 41, 111759 (2022).","journal-title":"Cell Rep."},{"key":"58910_CR32","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1172\/JCI95802","volume":"128","author":"S-H Jeong","year":"2018","unstructured":"Jeong, S.-H. et al. Hippo-mediated suppression of IRS2\/AKT signaling prevents hepatic steatosis and liver cancer. J. Clin. Investig. 128, 1010\u20131025 (2018).","journal-title":"J. Clin. Investig."},{"key":"58910_CR33","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1161\/01.RES.83.5.516","volume":"83","author":"L Wang","year":"1998","unstructured":"Wang, L., Ma, W., Markovich, R., Chen, J. W. & Wang, P. H. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. Circ. Res. 83, 516\u2013522 (1998).","journal-title":"Circ. Res."},{"key":"58910_CR34","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.tem.2020.05.004","volume":"31","author":"R Vigneri","year":"2020","unstructured":"Vigneri, R., Sciacca, L. & Vigneri, P. Rethinking the relationship between insulin and cancer. Trends Endocrinol. Metab. 31, 551\u2013560 (2020).","journal-title":"Trends Endocrinol. Metab."},{"key":"58910_CR35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41568-020-0295-5","volume":"20","author":"EJ Gallagher","year":"2020","unstructured":"Gallagher, E. J. & LeRoith, D. Hyperinsulinaemia in cancer. Nat. Rev. Cancer 20, 629\u2013644 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"58910_CR36","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.molcel.2020.04.035","volume":"78","author":"JM Cleary","year":"2020","unstructured":"Cleary, J. M., Aguirre, A. J., Shapiro, G. I. & D\u2019Andrea, A. D. Biomarker-guided development of DNA repair inhibitors. Mol. Cell 78, 1070\u20131085 (2020).","journal-title":"Mol. Cell"},{"key":"58910_CR37","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1158\/0008-5472.CAN-21-2997","volume":"82","author":"Z Wilson","year":"2022","unstructured":"Wilson, Z. et al. ATR inhibitor AZD6738 (Ceralasertib) exerts antitumor activity as a monotherapy and in combination with chemotherapy and the PARP inhibitor olaparib. Cancer Res. 82, 1140\u20131152 (2022).","journal-title":"Cancer Res."},{"key":"58910_CR38","doi-asserted-by":"publisher","first-page":"e005041","DOI":"10.1136\/jitc-2022-005041","volume":"10","author":"M Kwon","year":"2022","unstructured":"Kwon, M. et al. Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer. J. Immunother. Cancer 10, e005041 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"58910_CR39","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jconrel.2024.03.057","volume":"369","author":"Z Pan","year":"2024","unstructured":"Pan, Z. et al. Disrupting glycolysis and DNA repair in anaplastic thyroid cancer with nucleus-targeting platinum nanoclusters. J. Control. Release 369, 517\u2013530 (2024).","journal-title":"J. Control. Release"},{"key":"58910_CR40","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos, V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 18, 134\u2013147 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"58910_CR41","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41586-019-1450-6","volume":"572","author":"MD Wellenstein","year":"2019","unstructured":"Wellenstein, M. D. et al. Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis. Nature 572, 538\u2013542 (2019).","journal-title":"Nature"},{"key":"58910_CR42","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","volume":"612","author":"R Kim","year":"2022","unstructured":"Kim, R. et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature 612, 338\u2013346 (2022).","journal-title":"Nature"},{"key":"58910_CR43","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41586-023-06511-9","volume":"621","author":"C Wang","year":"2023","unstructured":"Wang, C. et al. CD300ld on neutrophils is required for tumour-driven immune suppression. Nature 621, 830\u2013839 (2023).","journal-title":"Nature"},{"key":"58910_CR44","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","volume":"22","author":"CC Hedrick","year":"2022","unstructured":"Hedrick, C. C. & Malanchi, I. Neutrophils in cancer: heterogeneous and multifaceted. Nat. Rev. Immunol. 22, 173\u2013187 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"58910_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41586-020-2394-6","volume":"583","author":"L Yang","year":"2020","unstructured":"Yang, L. et al. DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25. Nature 583, 133\u2013138 (2020).","journal-title":"Nature"},{"key":"58910_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35096-6","volume":"13","author":"Q Sui","year":"2022","unstructured":"Sui, Q. et al. Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer. Nat. Commun. 13, 7316 (2022).","journal-title":"Nat. Commun."},{"key":"58910_CR47","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190354","volume":"217","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Interleukin-17\u2013induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer. J. Exp. Med. 217, e20190354 (2020).","journal-title":"J. Exp. Med."},{"key":"58910_CR48","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"58910_CR49","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1093\/bioinformatics\/btv178","volume":"31","author":"GJ Etherington","year":"2015","unstructured":"Etherington, G. J., Ramirez-Gonzalez, R. H. & MacLean, D. bio-samtools 2: a package for analysis and visualization of sequence and alignment data with SAMtools in Ruby. Bioinformatics 31, 2565\u20132567 (2015).","journal-title":"Bioinformatics"},{"key":"58910_CR50","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cell.2019.08.052","volume":"179","author":"Q Gao","year":"2019","unstructured":"Gao, Q. et al. Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma. Cell 179, 561\u2013577.e22 (2019).","journal-title":"Cell"},{"key":"58910_CR51","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214\u2013218 (2013).","journal-title":"Nature"},{"key":"58910_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"58910_CR53","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.cell.2019.03.030","volume":"177","author":"S Vasaikar","year":"2019","unstructured":"Vasaikar, S. et al. Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities. Cell 177, 1035\u20131049.e19 (2019).","journal-title":"Cell"},{"key":"58910_CR54","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.1021\/pr200611n","volume":"10","author":"T Taus","year":"2011","unstructured":"Taus, T. et al. Universal and confident phosphorylation site localization using phosphoRS. J. Proteome Res. 10, 5354\u20135362 (2011).","journal-title":"J. Proteome Res."},{"key":"58910_CR55","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature13438","volume":"513","author":"B Zhang","year":"2014","unstructured":"Zhang, B. et al. Proteogenomic characterization of human colon and rectal cancer. Nature 513, 382\u2013387 (2014).","journal-title":"Nature"},{"key":"58910_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran, D., Hu, Z. & Butte, A. J. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18, 220 (2017).","journal-title":"Genome Biol."},{"key":"58910_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112102","volume":"133","author":"L Bao","year":"2024","unstructured":"Bao, L. et al. Targeting SIGLEC15 as an emerging immunotherapy for anaplastic thyroid cancer. Int. Immunopharmacol. 133, 112102 (2024).","journal-title":"Int. Immunopharmacol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58910-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58910-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58910-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T01:01:38Z","timestamp":1744765298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58910-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58910"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58910-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]},"assertion":[{"value":"19 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3601"}}